Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination Therapy in Treatment of Chronic Hepatitis C Infection in Egyptian Children With Gaucher Disease
Conditions
Interventions
Ledipasvir/Sofosbuvir
Locations
1
Egypt
Mansoura University Children Hospital, Ped Gastroenteroloy and Hepatology Unit
Al Mansurah, Dakahliya, Egypt
Start Date
April 3, 2018
Primary Completion Date
April 1, 2019
Completion Date
October 1, 2019
Last Updated
October 30, 2018
NCT07223944
NCT04378439
NCT06953479
NCT07429864
NCT05653232
NCT05992532
Lead Sponsor
Mansoura University Children Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions